Cationic lipids for gene delivery in vitro and in vivo

Expert Opinion on Therapeutic Patents

Volumn 16, Issue 6, 2006, Pages 825-844

  Rao, N Madhusudhana ^a   Gopal, Vijaya ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cationic lipid; Cell uptake; Cholesterol; Gene delivery; Gene therapy; Helper lipid; Liposome; Nuclear import; Nucleic acid; Stability; Transfection

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ADENOVIRUS VECTOR; AMMONIA; ARSENIC DERIVATIVE; CARBAMIC ACID DERIVATIVE; CHLOROQUINE; CHOLESTEROL; DIOCTADECYLAMIDOGLYCYLSPERMINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA; DNA VACCINE; FOLIC ACID; GANGLIOSIDE; GLYCEROL; GUANIDINE DERIVATIVE; HALOPERIDOL; HISTIDINE; HYBRID PROTEIN; INTERCALATING AGENT; LIPID; LIPOPLEX; MACROGOL; MELITTIN; NUCLEIC ACID; PEPTIDE DERIVATIVE; PROTEIN P53; SMALL INTERFERING RNA; SYNTHETIC PEPTIDE; TRANSFERRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN;

BIOSAFETY; CELL INTERACTION; CELL METABOLISM; CELL TRANSPORT; CELL TYPE; CHEMICAL PARAMETERS; CHEMISTRY; CLINICAL PROTOCOL; CYTOPLASM; DRUG CLEARANCE; DRUG DESIGN; DRUG FORMULATION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MOLECULAR STABILITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR IMPORT; PATENT; PUBLISHING; REVIEW; SQUAMOUS CELL CARCINOMA; SYNTHESIS; VIRAL GENE DELIVERY SYSTEM;

EID: 33745477456     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.16.6.825     Document Type: Review

References (151)

1. FELGNER PL, RHODES G: Gene therapeutics. Nature (1991) 349:351-352.
2. SCHATZLEIN AG: Non-viral vectors in cancer gene therapy: principles and progress. Anti-Cancer Drugs (2001) 12:275-304.
3. DUZGUNES N, PRETZER E, SIMOES S et al.: Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells. Mol. Membr. Biol. (1999) 16:111-118.
4. SORENSEN DR, LEIRDAL M, SIOUD M: Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. (2003) 327:761-766.
5. COTTEN M, WAGNER E: Non-viral approaches to gene therapy. Curr. Opin. Biotechnol. (1993) 4:705-710.
6. FARHOOD H, GAO X, SON K et al.: Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann. NY Acad. Sci. (1994) 716:23-34.
7. LIU F, HUANG L: Development of non-viral vectors for systemic gene delivery. J. Control. Release (2002) 78:259-266.
8. ZHENZHEN L, JIUCHUN Z, KE W et al.: Health biotechnology in China-reawakening of a giant. Nat. Biotechnol. (2004) 22 Suppl.:DC13-DC18.
9. PENG Z: Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. (2005) 16:1016-1027.
10. BEHR JP: Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. Bioconjug. Chem. (1994) 5:382-389.
11. CHEN WC, HUANG L: Non-viral vector as vaccine carrier. Adv. Genet. (2005) 54:315-337.
12. LI S, HUANG L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. (1997) 4:891-900.
13. NISHIKAWA M, HUANG L: Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. (2001) 12:861-870.
14. MILLER AD: Retrovirus packaging cells. Hum. Gene Ther. (1990) 1:5-14.
15. VARGA CM, WICKHAM TJ, LAUFFENBURGER DA: Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design. Biotechnol. Bioeng, (2000) 70:593-605.
16. MEUNIER-DURMORT C, PICART R, RAGOT T et al: Mechanism of adenovirus improvement of cationic liposome-mediated gene transfer. Biochim. Biophys. Acta (1997) 1330:8-16.
17. HOCK RA, MILLER AD: Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells. Nature (1986) 320:275-277.
18. WOLFF JA. Naked DNA transport and expression in mammalian cells. Neuromuscul. Disord. (1997) 7:314-318.
19. WOLFF JA, BUDKER V: The mechanism of naked DNA uptake and expression. Adv. Genet. (2005) 54:3-20.
20. FELGNER PL, GADEK TR, HOLM M et al: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413-7417.
21. ZHANG S, XU Y, WANG B et al.: Cationic compounds used in lipoplexes and polyplexes for gene delivery. J. Control. Release (2004) 100:165-180.
22. ELOUAHABI A, RUYSSCHAERT JM: Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. (2005) 11:336-347.
23. MARTIN B, SAINLOS M. AISSAOUI A et al.: The design of cationic lipids for gene delivery. Curr. Pharm. Des (2005) 11:375-394.
24. NICULESCU-DUVAZ D, HEYES J, SPRINGER CJ: Structure-activity relationship in cationic lipid mediated gene transfection. Curr. Med. Chem. (2003) 10:1233-1261.
25. JARNAGIN WR, DEBS RJ, WANG SS, BISSELL DM: Cationic lipid-mediated transfection of liver cells in primary culture. Nucleic Acids Res. (1992) 20:4205-4211.
26. AUDOUY S, HOEKSTRA D: Cationic lipid-mediated transfection in vitro and in vivo (review). Mol. Membr. Biol. (2001) 18:129-143.
27. MEDINA-KAUWE LK, XIE J, HAMM-ALVAREZ S: Intracellular trafficking of nonviral vectors. Gene Ther. (2005) 12:1734-1751.
28. MATULIS D, ROUZINA I, BLOOMFIELD VA: Thermodynamics of cationic lipid binding to DNA and DNA condensation: roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. (2002) 124:7331-7342.
29. PITARD B: Supramolecular assemblies of DNA delivery systems. Somat. Cell Mot. Genet. (2002) 27:5-15.
30. ZUHORN IS, HOEKSTRA D: On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: is that the question? J. Membr. Biol. (2002) 189:167-179.
31. MAY S, HARRIES D, BEN SHAUL A: The phase behavior of cationic lipid-DNA complexes. Biophys. J. (2000) 78:1681-1697.
32. CONGIU A, POZZI D, ESPOSITO C et al: Correlation between structure and transfection efficiency: a study of DC-Chol-DOPE/DNA complexes. Colloids Surf. B Biointerfaces. (2004) 36:43-48.
33. GERSHON H, GHIRLANDO R, GUTTMAN SB, MINSKY A: Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemisny (1993) 32:7143-7151.
34. GONCALVES E, DEBS RJ, HEATH TD: The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes. Biophys. J. (2004) 86:1554-1563.
35. ROSS PC, HUI SW: Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. (1999) 6:651-659.
36. SCHREIER H, GAGNE L, BOCK T et al.: Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes. Pharm. Acta Helv. (1997) 72:215-223.
37. HIRKO A, TANG F, HUGHES JA: Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem. (2003) 10:1185-1193.
38. FASBENDER AJ, ZABNER J, WELSH MJ: Optimization of cationic lipid-mediated gene transfer to airway epithelia. Am. J. Physiol (1995) 269:L45-L51.
39. LIU D, REN T, GAO X. Cationic transfection lipids. Curr. Med. Chem. (2003) 10:1307-1315.
40. BOUSSIF O, ZANTA MA, BEHR JP: Optimized galenics; improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. (1996) 3:1074-1080.
41. PRASAD TK, RANGARAJ N, RAO NM: Quantitative aspects of endocytic activity in lipid-mediated transfections. FEBS Lett. (2005) 579:2635-2642.
42. RAKHMANOVA VA, POZHARSKI EV MACDONALD RC: Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures. J. Membr. Biol (2004) 200:35-45.
43. WOODLE MC, LASIC DD: Sterically stabilized liposomes. Biochim. Biophys. Acta (1992) 1113:171-199.
44. MILLER AD: Cationic liposomes for gene therapy. Angew. Chem. Int. Ed Engl. (1998) 37:1768-1785.
45. BANERJEE R, DAS PK, SRILAKSHMI GV et al: Novel series of non-glycerol-based cationic transfection lipids for use in liposomal gene delivery. J. Med. Chem. (1999) 42:4292-4299.
46. LEE RJ, HUANG L: Lipidic vector systems for gene transfer. Crit Rev. Ther. Drug Carrier Syst. (1997) 14:173-206.
47. FELGNER PL: Nonviral strategies for gene therapy. Sci. Am. (1997) 276:102-106.
48. LIU Y, FONG S, DEBS RJ: Cationic liposome-mediated gene delivery in vivo. Methods Enzymol. (2003) 373:536-550.
49. MILLER AD: The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. (2003) 10:1195-1211.
50. POZHARSKI E, MACDONALD RC: Thermodynamics of cationic lipid-DNA complex formation as studied by isothermal titration calorimetry. Biophys. J. (2002) 83:556-565.
51. TARAHOVSKY YS, KOYNOVA R, MACDONALD RC: DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys. J. (2004) 87:1054-1064.
52. SMYTH TN: Cationic liposomes as in vivo delivery vehicles. Curr Med. Chem. (2003) 10:1279-1287.
53. SAFINYA CR: Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr. Opin. Struct. Biol. (2001) 11:440-448.
54. HOPE MJ, MUI B, ANSELL S, AHKONG QF: Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review). Mol. Membr. Biol. (1998) 15:1-14.
55. LIN AJ, SLACK NI., AHMAD A et al.: Structure and structure-function studies of lipid/plasmid DNA complexes. J. Drug Target (2000) 8:13-27.
56. DE KRUIJFF B: Lipid polymorphism and biomembrane function. Curr. Opin. Chem. Biol. (1997) 1:564-569.
57. CULLIS PR, DE KRUIJFF B, VERKLEIJ AJ, HOPE MJ: Lipid polymorphism and membrane fusion. Biochem. Soc. Trans. (1986) 14:242-245.
58. PESCHKA R, DENNEHY C, SZOKA FC Jr: A simple in vitro model to study the release kinetics of liposome encapsulated material. J. Control. Release (1998) 56:41-51.
59. LEGENDRE JY, SZOKA FC Jr: Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. (1992) 9:1235-1242.
60. EWERT K, EVANS HM, AHMAD A et al.: Lipoplex structures and their distinct cellular pathways. Adv. Genet. (2005) 53PA:119-155.
61. FELGNER PL, TSAI YJ, SUKHU L et al.: Improved cationic lipid formulations for in vivo gene therapy. Ann. NY Acad. Sci. (1995) 772:126-139.
62. EWERT K, SLACK NL, AHMAD A et al.: Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level. Curr. Med Chem. (2004) 11:133-149.
63. PRASAD TK, GOPAL V. MADHUSUDHANA RN: Structural changes in DNA mediated by cationic lipids alter in vitro transcriptional activity at low charge ratios. Biochim. Biophys. Acta (2003) 1619:59-69.
64. PRASAD TK, GOPAL V, RAO NM: Cationic lipids and cationic ligands induce DNA helix denaturation: detection of single stranded regions by KMnO4 probing. FEBS Lett. (2003) 552:199-206.
65. THOMPSON B, MIGNET N, HOFLAND H et al.: Neutral postgrafted colloidal particles for gene delivery. Bioconjug. Chem. (2005) 16:608-614.
66. FUNHOFF AM, MONGE S, TEEUWEN R et al.: PEG shielded polymeric double-layered micelles for gene delivery. J. Control. Release (2005) 102:711-724.
67. LI S, RIZZO MA, BHATTACHARYA S, HUANG L: Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. (1998) 5:930-937.
68. MEYER O, KIRPOTIN D, HONG K et al.: Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. (1998) 273:15621-15627.
69. WHEELER JJ, PALMER L, OSSANLOU M et al.: Stabilized plasmid-lipid particles. construction and characterization. Gene Ther. (1999) 6:271-281.
70. DAN LUO W, SALTZMAN D: Enhancement of transfection by physical concentration of DNA at the cell surface. Nat. Biotechnol. (2000) 18:893-895.
71. PIRES P, SIMOES S, NIR S et al.: Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells. Biochim. Biophys. Acta (1999) 1418:71-84.
72. KAWAKAMI S, YAMASHITA F, NISHIKAWA M et al.: Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. (1998) 252:78-83.
73. DEONARAIN MP: Ligand-targeted receptor-mediated vectors for gene delivery. Expert Opin. Ther. Patents (1998) 8:53-69.
74. SUN X, HAI L, WU Y et al.: Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J. Drug Target (2005) 13:121-128.
75. LEE RJ, HUANG L: Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. (1996) 271:8481-8487.
76. MUKHERJEE A, PRASAD TK, RAO NM, BANERJEE R: Haloperidol-associated Stealth liposomes: a potent carrier for delivering genes to human breast cancer cells. J. Biol. Chem. (2005) 280:15619-15627.
77. TROS D, I, DUZGUNES N: Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim. Biophys. Acta (2000) 1463:333-342.
78. LI W, NICOL F, SZOKA FC Jr: GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. (2004) 56:967-985.
79. ZABNER J,FASBENDER AJ, MONINGER T et al.: Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. (1995) 270:18997-19007.
80. ELOUAHABI A, THIRY M, PECTOR V et al.: Calorimetry of cationic liposome-DNA complex and intracellular visualization of the complexes. Methods Enzymol. (2003) 373:313-332.
81. PANTAZATOS DP, MACDONALD RC: Directly observed membrane fusion between oppositely charged phospholipid bilayers. J. Membr. Biol. (1999) 170:27-38.
82. WIETHOFF CM, MIDDAUGH CR: Barriers to nonviral gene delivery. J. Pharm. Sci. (2003) 92:203-217.
83. ZELPHATI O, SZOKA FC Jr: Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA (1996) 93:11493-11498.
84. XU Y, SZOKA FC Jr: Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (1996) 35:5616-5623.
85. BENTZ J, ELLENS H, LAI MZ et al.: On the correlation between HII phase and the contact-induced destabilization of phosphatidylethanolamine-containing membranes. Proc. Natl. Acad. Sci. USA (1985) 82:5742-5745.
86. BRASSEUR R, KILLIAN JA, DE KRUIJFF B, RUYSSCHAERT JM: Conformational analysis of gramicidin-gramicidin interactions at the air/water interface suggests that gramicidin aggregates into tube-like structures similar as found in the gramicidin-induced hexagonal HII phase. Biochim. Biophys. Acta (1987) 903:11-17.
87. ZUHORN IS, OBERLE V, VISSER WH et al.: Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency, Biophys. J. (2002) 83:2096-2108.
88. KUMAR VV, PICHON C, REFREGIERS M et al.: Single histidine residue in head-group region is sufficient to impart remarkable gene transfection properties to cationic lipids: evidence for histidine-mediated membrane fusion at acidic pH. Gene Ther. (2003) 10:1206-1215.
89. SOLODIN I, BROWN CS, BRUNO MS et al.: A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry (1995) 34:13537-13544.
90. COLL JL, CHOLLET P, BRAMBILLA E et al.: In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum. Gene Ther. (1999) 10:1659-1666.
91. RUPONEN M, HONKAKOSKI P, RONKKO S et al.: Extracellular and intracellular barriers in non-viral gene delivery. J. Control Release (2003) 93:213-217.
92. TORCHILIN VP, LEVCHENKO TS, RAMMOHAN R et al.: Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA (2003) 100:1972-1977.
93. ZUHORN IS, BAKOWSKY U, POLUSHKIN E et al.: Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol. Ther. (2005) 11:801-810.
94. VALLEE RB, SHEETZ MP: Targeting of motor proteins. Science (1996) 271:1539-1544.
95. VARGA CM, HONG K, LAUFFENBURGER DA: Quantitative analysis of synthetic gene delivery vector design properties. Mol. Ther. (2001) 4:438-446.
96. DEAN DA, STRONG DD, ZIMMER WE: Nuclear entry of nonviral vectors. Gene Ther. (2005) 12:881-890.
97. LECHARDEUR D, SOHN KJ, HAARDT M et al: Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther. (1999) 6:482-497.
98. SALMAN H, ZBAIDA D, RABIN Y et al.: Kinetics and mechanism of DNA uptake into the cell nucleus. Proc. Natl. Acad. Sci. USA (2001) 98:7247-7252.
99. DWYER JD, BLOOMFIELD VA: Brownian dynamics simulations of probe and self-diffusion in concentrated protein and DNA solutions. Biophys. J. (1993) 65:1810-1816.
100. GASIOROWSKI JZ, DEAN DA: Mechanisms of nuclear transport and interventions. Adv. Drug Deliv. Rev. (2003) 55:703-716.
101. BRUNNER S, FURTBAUER E, SAUER T et al.: Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. (2002) 5:80-86.
102. BRUNNER S, SAUER T, CAROTTA S et al.: Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. (2000) 7:401-407.
103. LIM W, HEARLE N, SHAH B et al.: Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br. J. Cancer (2003) 89:308-313.
104. NEVES C, BYK G, SCHERMAN D, WILS P: Coupling of a targeting peptide to plasmid DNA by covalent triple helix formation. FEBS Lett. (1999) 453:41-45.
105. DEAN DA, DEAN BS, MULLER S, SMITH LC: Sequence requirements for plasmid nuclear import. Exp. Cell Res. (1999) 253:713-722.
106. VACIK J, DEAN BS, ZIMMER WE, DEAN DA: Cell-specific nuclear import of plasmid DNA. Gene Ther. (1999) 6:1006-1014.
107. PRASAD TK, RAO NM: The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid-mediated DNA delivery. Cell Mol. Biol. Lett. (2005) 10:203-215.
108. AKITA H, ITO R, KHALIL IA et al.: Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol. Ther. (2004) 9:443-451.
109. SCHERMAN D, BESSODES M, CAMERON B et al.: Application of lipids and plasmid design for gene delivery to mammalian cells. Curr. Opin. Biotechnol. (1998) 9:480-485.
110. DASS CR: Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J. Mol. Med. (2004) 82:579-591.
111. DAVIS SC, SZOKA FC Jr: Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. Bioconjug. Chem. (1998) 9:783-792.
112. HONG K, ZHENG W, BAKER A. PAPAHADJOPOULOS D: Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett. (1997) 400:233-237.
113. KIM JK, CHOI SH, KIM CO et al.: Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency. J. Pharm. Pharmacol. (2003) 55:453-460.
114. TSAO YS, HUANG L: Sendai virus induced leakage of liposomes containing gangliosides. Biochemistry (1985) 24:1092-1098.
115. LEE CH, HSIAO M, TSENG YL, CHANG FH: Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody. J. Biomed. Sci. (2003) 10:337-344.
116. TERAISHI F, UMEOKA T, SAITO T et al.: A novel method for gene delivery and expression in esophageal epithelium with fibrin glues containing replication-deficient adenovirus vector. Surg. Endosc. (2003) 17:1845-1848.
117. TEMPLETON NS: Cationic liposome-mediated gene delivery in vivo. Biosci. Rep. (2002) 22:283-295.
118. GAO X, HUANG L: A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. (1991) 179:280-285.
119. KUMAR VV, SINGH RS, CHAUDHURI A: Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr. Med. Chem. (2003) 10:1297-1306.
120. REGE K. LADIWALA A, HU S et al.: Investigation of DNA-binding properties of an aminoglycoside-polyamine library using quantitative structure-activity relationship (QSAR) models. J. Chem. Inf. Model. (2005) 45:1854-1863.
121. FELGNER JH, KUMAR R, SRIDHAR CN et al.: Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. (1994) 269:2550-2561.
122. NANTZ MH, LI L, ZHU J et al.: Inductive electron-withdrawal from ammonium ion headgroups of cationic lipids and the influence on DNA transfection. Biochim. Biophys. Acta (1998) 1394:219-223.
123. SINGH RS, MUKHERJEE K, BANERJEE R et al.: Anchor dependency for non-glycerol based cationic lipofectins: mixed bag of regular and anomalous transfection profiles. Chemistry. (2002) 8:900-909.
124. LAXMI AA, VIJAYALAKSHMI P, KAIMAL TN et al.: Novel non-glycerol-based cytofectins with lactic acid-derived head groups. Biochem. Biophys. Res. Commun. (2001) 289:1057-1062.
125. RAO NM, CHAUDHURI A: Non-glycerol based lipofectins for gene delivery. Cell Mol. Biol. Lett. (2002) 7:296.
126. BENNETT MJ, ABERLE AM, BALASUBRAMANIAM RP et al.: Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity. J. Med. Chem. (1997) 40:4069-4078.
127. VAN DW, I, WAGENAAR A, MEEKEL AA et al.: Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery: Proc. Natl. Acad. Sci. USA (1997) 94:1160-1165.
128. MCGREGOR C, PERRIN C, MONCK M et al.: Rational approaches to the design of cationic gemini surfactants for gene delivery. J. Am. Chem. Soc. (2001) 123:6215-6220.
129. GAUCHERON J, SANTAELLA C, VIERLING P: Transfection with fluorinated lipoplexes based on fluorinated analogues of DOTMA, DMRIE and DPPES. Biochim. Biophys. Acta (2002) 1564:349-358.
130. LIU F, YANG J, HUANG L, LIU D: New cationic lipid formulations for gene transfer. Pharm. Res. (1996) 13:1856-1860.
131. MIZUGUCHI H, NAKAGAWA T, MORIOKA Y et al.: Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain. Biochem. Biophys. Res. Commun. (1997) 234:15-18.
132. REN T, ZHANG G, LIU F, LIU D: Synthesis and evaluation of vitamin D-based carionic lipids for gene delivery in vitro. Bioorg. Med. Chem. Lett. (2000) 10:891-894.
133. FUJIWARA T, HASEGAWA S, HIRASHIMA N et al.: Gene transfection activities of amphiphilic steroid-polyamine conjugates. Biochim. Biophys. Acta (2000) 1468:396-402.
134. WALKER S, SOFIA MJ, KAKARLA R et al.: Cationic facial amphiphiles: a promising class of transfection agents. Proc. Natl. Acad. Sci. USA (1996) 93:1585-1590.
135. ERBACHER P, BETTINGER T, BRION E et al.: Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival. J. Drug Target (2004) 12:223-236.
136. BEHR JP, DEMENEIX B, LOEFFLER JP, PEREZ-MUTUL J: Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc. Natl. Acad. Sci. USA (1989) 86:6982-6986.
137. COOPER RG, ETHERIDGE CJ, STEWART L et al.: Polyamine analogues of 3-[N-(N,N-dimethylaminoethane)carbamo yl]cholesterol (DC-Chol) as agents for gene delivery. Chem. Euro. J. (1998) 4:137-151.
138. BYK G, SCHERMAN D: Novel cationic lipids for gene delivery and gene therapy. Expert Opin. Ther. Patents (1998) 8:1125-1141.
139. LIN AJ, SLACK NL, AHMAD A et al.: Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. Biophys. J. (2003) 84:3307-3316.
140. LEE ER, MARSHALL J, SIEGEL CS et al.: Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. (1996) 7:1701-1717.
141. SAINLOS M, HAUCHECORNE M, OUDRHIRI N et al.: Kanamycin A-derived cationic lipids as vectors for gene transfection. Chembiochem. (2005) 6:1023-1033.
142. BOOMER JA, THOMPSON DH, SULLIVAN SM: Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer. Pharm. Res. (2002) 19:1292-1301.
143. ZHU M-Z, WU Q-H, ZHANG G et al.: Synthesis and evaluation of cationic lipids bearing cholesteryl groups for gene delivery in vitro. Bull. Chem. Soc. Jpn (2002) 75:2207-2213.
144. ZHU J, MUNN RJ, NANTZ MH: Self-cleaving ortho ester lipids: a new class of pH-vulnerable amphiphiles. J. Am. Chem. Soc. (2000) 122:2645-2646.
145. HOFLAND HE, MASSON C, IGINLA S et al.: Folate-targeted gene transfer in vivo. Mol. Ther. (2002) 5:739-744.
146. PASTORINO F, BRIGNOLE C, MARIMPIETRI D et al.: Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin. Cancer Res. (2003) 9:4595-4605.
147. GUPTA B, LEVCHENKO TS, TORCHILIN VP: Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv. Drug Deliv. Rev. (2005) 57:637-651.
148. AUDOUY SA, DE LEIJ LF, HOEKSTRA D, MOLEMA G: In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm. Res. (2002) 19:1599-1605.
149. PEDROSO DE LIMA MC, NEVES S, FILIPE A, DUZGUNES N, SIMOES S: Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem. (2003) 10:1221-1231.
150. GUO X, SZOKA FC Jr: Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate Bioconjug. Chem. (2001) 12:291-300.
151. LEE M, KIM SW: Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm. Res. (2005) 22:1-10.